Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Rating of Russian Retail Pharmacies (Q1 – Q2 2017)

Wednesday, August 9, 2017

Against rather poor growth rates in the Russian pharmaceutical retail market, chain retailers have not ceased to actively consolidate. These deals lead to the formation of new industry leaders that sweep away everything on their way to the top, or they simply strengthen the positions of certain players in local markets. The battles for the top on the country and regional levels almost do not concern market players, which are on another level. These players are still one of the main operating forces of the Russian pharmaceutical retail industry both on a regional scale (this is mostly typical for the republics of the North Caucasus), and in the market in general.

There are about 10,800 independent pharmacies in Russia (almost 20%), and they control 19.8% of the market share in monetary terms. In addition to independent pharmacies, there are about 2,100 small pharmacy chains (3 to 9 pharmacies), which make around 7,200 pharmacies and about 9.8% of the share in monetary terms. These two conglomerates are the largest formation of the Russian pharmaceutical retail, and they are often more successful in selling pharmaceuticals than larger chains.

However, this segment of the market is still a kind of terra incognita for pharmaceutical companies. This segment is difficult to influence and interact with. The industry is also quite sure about the imminent end of the independent pharmaceutical retail, although, in our opinion, it is too early to tell.

Read more about rating of Russian retail pharmacies (Q1 2017 performance) here: http://rncph.com/news/19_05_2017

Tab 1. Top 15 pharmacies with the largest share in the retail market of pharmaceuticals in Russia (Q1 – Q2 2017)

Share: